Background Inflammation biomarkers have been introduced into clinical practice for risk-
rating in treatment of patients with cancer. We aimed to confirm the prognostic role of platelet …

Simple Summary Inflammation plays a major role in cancer development and progression
and has the potential to be used as a prognostic marker in cancer. Previous studies have …

Background The purposes of this systematic review and meta‐analysis were to investigate
the relationship between the neutrophil‐to‐lymphocyte ratio (NLR) and prognosis in head …

Chronic inflammation plays an important role in tumor progression. The aim of this analysis
was to evaluate whether inflammatory biomarkers such as the Glasgow prognostic score …

Purpose Several studies have found an association between peripheral inflammatory cells
and outcome. However, no study has explored their impact specifically in elderly patients …

Background The peripheral blood platelet–lymphocyte ratio (PLR) has been proposed as an
indicator for evaluating systemic inflammatory responses in cancer-bearing patients. While …

Purpose To assess the prognostic value of neutrophil-to-lymphocyte ratio (NLR) in patients
with International Union Against Cancer (UICC)–staged III/IVA, B nasopharyngeal …

Background Poor nutritional status is associated with progression and advanced disease in
patients with cancer. The prognostic nutritional index (PNI) may represent a simple method …

Background A recent study indicated that the Advanced Lung Cancer Inflammation Index
(ALI) could predict overall survival (OS) in patients with non–small-cell lung cancer …

Purpose: Hematological parameters are considered to be associated with prognosis in
various cancers. We designed a meta-analysis to evaluate the prognostic significance of …